IVIEW Therapeutics
Biotechnology company developing novel therapeutics for ocular diseases, with focus on retinal and other eye conditions.
Location
Philadelphia, Pennsylvania, USA
Founded
2019
Categories
biotech, ophthalmology, ocular-disease, therapeutics
Notes
IVIEW Therapeutics is a biotechnology company focused on developing novel therapeutics for ocular diseases. The company is working on treatments for conditions affecting the retina and other parts of the eye, addressing significant unmet medical needs in ophthalmology.
Eye diseases including age-related macular degeneration, diabetic retinopathy, and glaucoma affect millions of patients globally, creating significant demand for new therapeutic approaches.
IVIEW Therapeutics is backed by BioAdvance, a life sciences investment organization focused on early-stage companies in the Mid-Atlantic region.
Team
- Leadership team with ophthalmology drug development experience
Additional Research Findings
- Founded circa 2019, based in Philadelphia area
- Portfolio company of BioAdvance
- Ocular/ophthalmology therapeutic focus
- Retinal disease programs
- Early-stage development company
- Part of Philadelphia biotech ecosystem